As of December 2024, GemVax&KAEL has a market cap of $341.75M. This makes GemVax&KAEL the world's 13885th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $306.96M | -6.33% |
2023 | $327.68M | 12.54% |
2022 | $291.17M | -32.95% |
2021 | $434.28M | 17.73% |
2018 | $368.89M | 4.91% |
2017 | $351.62M | -2.06% |
2016 | $359.02M | -35.48% |
2015 | $556.42M | 45.48% |
2014 | $382.46M | 30.25% |
2013 | $293.63M | -63.38% |
2012 | $801.94M | - |